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ABSTRACT Senescent-cell antigen is a "neo-antigen"
that appears on the surface of senescent cells and initiates IgG
binding and cellular removal. As an approach to evaluating
oxidation as a possible mechanism for generation of senescent-
cell antigen, we studied erythrocytes from vitamin E-deficient
rats. Vitamin E is localized primarily in cellular membranes.
Its major role is the termination of free-radical chain reactions
propagated by the polyunsaturated fatty acids of membrane
phospholipids. Results of our studies indicate that erythrocytes
of all ages from vitamin E-deficient rats behave like old
erythrocytes from normal rats, as determined by their suscep-
tibility to phagocytosis, IgG binding, anion transport ability,
and glyceraldehyde-3-phosphate dehydrogenase activity. In-
creased breakdown products of band 3 were observed with
immunoblotting in membranes of erythrocytes from vitamin
E-deficient rats. Breakdown products of band 3 are known to
increase as cells age in normal individuals. The data suggest
that oxidation may be a possible mechanism for erythrocyte
aging and generation of senescent-cell antigen in vivo.
One hypothesis for the removal of senescent erythrocytes is
that a "neo-antigen" appears on the surface of senescent
cells leading to IgG binding and cellular removal (1-10). The
"neo-antigen" is recognized by the antigen binding, Fab,
region (3, 10, 11) of a specific IgG autoantibody in serum that
attaches to it and initiates the removal of cells by macro-
phages (1-4). A number ofstudies performed by us (1-11) and
by others have demonstrated the presence of IgG on senes-
cent, damaged, and stored erythrocytes (12-20, 1). In addi-
tion, workers in several laboratories have recently presented
evidence that IgG binding is also involved in the removal of
erythrocytes in diseases such as thalassemia (21) and sickle
cell anemia (22, 23). IgG has also been implicated in the
removal of aging platelets (24).
We have named the neo-antigen on senescent erythrocytes
"senescent-cell antigen" (5). Senescent-cell antigen is a
glycosylated 4.5 region polypeptide that appears to be de-
rived from band 3 (5, 8, 10, 25-27). Senescent-cell antigen is
located on an extracellular portion of band 3 that includes
most ofthe 38-kDa carboxyl-terminal segment and 30% ofthe
17-kDa anion-transport region (27).
Although the senescent-cell antigen was first demonstrated
on the surface of senescent human erythrocytes (1, 2), it has
since been demonstrated on the surface of lymphocytes,
polymorphonuclear leukocytes, platelets, embryonic kidney
cells, and adult liver cells (5). A molecule immunologically
related to band 3, the molecule from which senescent-cell
antigen is derived, has been observed on all cells examined
(28, 29).
Workers in several different laboratories agree that ap-
pearance of senescent-cell antigen initiates IgG binding and
destruction of erythrocytes (1-20, 1). However, they do not
agree on the molecular changes responsible for generating the
antigen. Our evidence suggests that senescent-cell antigen is
derived from band 3, probably by degradation (10, 25-31);
Lutz and his colleagues have suggested that senescent-cell
antigen is a dimer ofband 3 (32); Sayare et al. (33) have shown
that band 3 can cross-link with hemoglobin under oxidative
conditions; and Low et al. (34) have presented evidence that
clustered band 3 can generate senescent-cell antigen. These
membrane events are not mutually exclusive. Indeed, we
have postulated that generation of senescent-cell antigen may
result from oxidation-induced cross-linking followed by
proteolysis (26).
As an approach to evaluating oxidation as a possible
mechanism responsible for generation of senescent-cell an-
tigen, we studied erythrocytes from vitamin E-deficient rats.
The importance of vitamin E as an antioxidant, providing
protection against free radical-induced membrane damage,
has been well documented (35-38). Vitamin E is primarily
localized in cellular membranes, and a major role of vitamin
E is the termination of free-radical chain reactions propagat-
ed by the polyunsaturated fatty acids of membrane
phospholipids. Vitamin E-deficient erythrocytes are defec-
tive in their ability to scavenge free radicals (38, 39).
The erythrocyte has many potential sources for generating
free radicals. Hemoglobin is known to catalyze lipid
peroxidation as well as enhance the decomposition of lipid
hydroperoxides to the corresponding free radicals (40).
Autooxidation of oxyhemoglobin to methemoglobin results
in the generation ofa superoxide radical (41, 42). The reaction
of a superoxide radical with peroxides in the erythrocytes
produces highly reactive intermediates, such as the hydroxyl
radical ('OH). These radicals in turn react with the lipid and
protein components of the membrane, damaging its integrity
and leading to eventual hemolysis of the cell (40). Lipid
peroxidation in the erythrocyte membrane can result in
accumulation of an aldehyde, which can cause a reduction in
deformability (43, 44) and formation of irreversibly sickled
cells (45).
In humans, vitamin E deficiency shortens erythrocyte life
span, causing a compensated hemolytic anemia in patients
with cystic fibrosis (45). In newborns, vitamin E deficiency
causes a hemolytic anemia that develops by 4 to 6 weeks of
age (46).
Specific biochemical alterations in the membrane of eryth-
rocytes from vitamin E-deficient rhesus monkeys have been
described (47, 48). Furthermore, vitamin E deficiency rep-
resents a "physiological" method for rendering cells suscep-
$Wegner, G., Tannert, C. H., Maretzki, D., Schlosser, W. &
Strauss, D., Ninth International Symposium on Structure and
Function of Erythroid Cells, Aug. 27, 1980, Berlin, p. 57 (abstr.).
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tible to free-radical damage and may simulate conditions
encountered in situ. In contrast, methods that have been used
to induce oxidative damage in vitro, such as exposing cells to
malondialdehyde, peroxide, etc., result in numerous pro-
nounced membrane changes that are not observed in cells
aged in situ (unpublished observations).
The role of free-radical damage in aging has received a
great deal of attention. It is interesting that there is a
correlation between life span and natural antioxidant levels in
a variety of species and that the level of such antioxidants
appears to correlate with metabolic activity of individual
species (49). Evidence for free-radical damage associated
with aging is the presence of lipofuscin and ceroid, so called
aging pigments, which represent accumulated breakdown
products of polyunsaturated fatty acids and proteins. It has
been suggested that free radicals may be mediators of aging
and specific pathologies, such as inflammation, arthritis,
adult respiratory distress syndrome, and other conditions
(50, 51). Free radicals have also been implicated as causative
agents in mutagenesis and carcinogenesis as well as causing
cross-linking of macromolecules and the formation of age
pigments (51).
Results of the experiments presented here indicate that
erythrocytes from vitamin E-deficient rats age prematurely.
The results suggest that oxidation may accelerate cellular
aging and may be a mechanism for generation of senescent-
cell antigen.
MATERIALS AND METHODS
Diet of Vitamin E-Deficient Rats. Weanling male Wistar-
Kyoto (W/K) rats (Charles River Breeding Laboratories)
were randomly separated into three groups of 12 rats each.
One group received a vitamin E-deficient diet (Dyets,
Bethlehem, PA). The second and third groups received the
identical diet supplemented with dl-a-tocopheryl acetate,
hereafter referred to as vitamin E, at 50 and 200 mg/kg,
respectively. Rats were tested at 11, 16, 20, and 30 wk after
being placed on their assigned diet. Rats fed a diet containing
no vitamin E are referred to as "deficient" rats, those
receiving vitamin E at 50 mg/kg are referred to as "normal,"
and those receiving 200 mg/kg are referred to as "high."
All animals were given food and water ad libitum, housed
in stainless steel wire floored cages, and kept on a 12-hr
light/dark cycle. Animals from each group were anesthetized
with metofane (Pittman-Moore, Washington Crossing, NJ)
and blood was collected by cardiac puncture. Blood was
collected in sterile tubes with CPDA1 as an anticoagulant.
Blood was shipped on ice from New Jersey to Texas.
Analysis was performed within 24 hr of collection. Since
samples from all groups were handled the same way, samples
from rats given normal amounts of vitamin E served as
controls for the effects of shipping as well as normal vitamin
E levels.
Addition ofVitamin E in Vitro. Vitamin E was added in vitro
to blood samples obtained from vitamin E-deficient rats in an
amount (1.6 mg/dl) necessary to bring the serum vitamin E
level to that of the level of rats fed diets containing vitamin
E at 200 mg/kg. D-a-tocopherol (1 mg) was dissolved in
absolute ethanol, and an aliquot was taken and diluted to a
concentration of 1.6 mg per dl of vitamin E in plasma. The
vitamin E was then added to whole blood, which was
incubated for 30 min at room temperature and then shipped
on ice. From previous experiments, we know that vitamin E
will equilibrate between plasma and erythrocytes within this
time.
Serum Analysis. Vitamin E levels were determined as
described using high-pressure liquid chromatography (52).
Haptoglobin and transferrin were determined on an automat-
ed Beckman Immunochemistry Analyzer II; iron and lactate
dehydrogenase (LDH) were determined with a DuPont Au-
tomatic Clinical Analyzer II; LDH isoenzymes were deter-
mined with a Helena Auto Scanner with Quick Quant II;
bilirubin was determined with a Beckman Automated
Stat/Routine Analyzer.
Cell Separation. Cells were separated into populations of
different ages on Percoll gradients as described (4).
Phagocytosis Assay. Rat erythrocytes were washed three
times with RPMI 1640 medium with 5% fetal calf serum. Ten
erythrocytes per macrophage were added to tubes containing
either human or mouse macrophages (1 x 106) as indicated in
the text. The human cell line used was U937; the mouse cell
line was WEHI-3. The phagocytosis assay was performed as
described (2-4, 53).
Immunoblotting. Polyacrylamide gel electrophoresis was
performed using 6-24% or 2-16% polyacrylamide gradient
gels and the discontinuous gel system of Laemmli (54).
Immunoblotting was performed as described (26, 53, 55).
Glycoprotein and Protein Stains. Polyacrylamide gels were
stained with silver stain followed by Coomassie blue (Bio-
Rad kit). This double-staining technique permits visualiza-
tion of both glycoproteins and proteins. Gels were scanned
with a laser scanning densitometer (LKB).
Glyceraldehyde-3-Phosphate Dehydrogenase Assay. Cells
were washed four times in 50-60 vol of phosphate-buffered
saline (pH 7.4) and lysed in "lysis buffer" (5 mM Na2HPO4/1
mM EDTA/1 mM EGTA/1 mM DFP, pH 7.4) at a concen-
tration of 2 x 108 cells per 0.1 ml. The hemolysates were
aliquotted and either assayed for glyceraldehyde-3-phos-
phate dehydrogenase or frozen at -80°C. Freezing and
thawing once did not affect the activity of the enzyme under
the conditions used. Glyceraldehyde-3-phosphate dehydrog-
enase was measured at 37°C in the forward reaction using the
method of Schrier (56) except that the volume of the reaction
mixture was reduced from 3 ml to 1 ml. D-Glyceraldehyde
3-phosphate was obtained from Sigma as the diethyl acetal
barium salt, which was deionized on Dowex 5OW (Sigma) and
heated for 3 min at 100°C to obtain the free aldehyde.
Anion Transport Measurements. The "self-exchange flux"
of sulfate was determined from the sulfate exchange at
Donnan equilibrium, essentially following the method of
Lepke and Passow (57) and Schnell et al. (58). Erythrocytes
were assayed either the same day or 1 day after the blood was
collected. Density separation was performed as described
above, and the cells were washed 4 times in 40 vol of saline.
"Influx" experiments were performed according to
Schnell et al. (58) with the following modifications (P.
Hallaway and J. W. Eaton, personal communication).
Washed cells were suspended at 3-4 x 108 cells per ml in
Hanks' balanced salt solution, containing various concentra-
tions of sulfate (pH 7.4) and equilibrated at 37°C for 1 hr.
RESULTS
Serum Vitamin E Levels. Serum vitamin E levels were
evaluated at the end of the experiment as an independent
means of determining whether the rats had been maintained
on the assigned diet. The serum vitamin E measurements
indicated that the assigned diets had been maintained (serum
vitamin E levels: high, 1.52, 1.54, and 1.56 mg/dl; normal,
0.88 and 1.1 mg/dl; deficient, <0.05, <0.05, and 0.18 mg/dl
(limits of detection, 0.05 mg/dl).
Hematologic and Serum Studies. Clinical studies indicated
accelerated destruction of erythrocytes and were consistent
with the vitamin E-deficient rats having a compensated
hemolytic anemia (Table 1) as is observed in vitamin E-
deficient humans. Serum haptoglobin was significantly re-
duced in vitamin E-deficient rats. Haptoglobin binds specif-
ically and tightly to the protein (globin) in hemoglobin. The
hemoglobin-haptoglobin complex is cleared within minutes
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Table 1. Hematologic and serum indices of vitamin E-deficient and control rats
Vitamin E diet Deficient +
Index High Normal Deficient vitamin E
RBC, x10-6 10.31 ± 0.08 10.39 ± 0.08 10.35 ± 0.14
Hb, g/dl 16.65 ± 0.12 16.76 ± 0.12* 16.26 ± 0.18
Hct, % 50.53 ± 0.38 51.26 ± 0.40* 49.6 ± 0.55
MCV, Am3 48.99 ± 0.21t 49.28 ± 0.14 47.84 ± 0.16
(n =9) (n =10) (n =11) (n = 9)
Haptoglobin 5.5 ± 0.2 5.9 ± 0.4 BDL
Fe 177 59 224 122 229 175 149 ± 61
TIBC, % 28.9 ± 0.4 29.7 ± 1.3 31.1 ± 0.1 30.8 ± 2.2
Four experiments were performed. Serum data are from the fourth experiment. The number of rats
(n) from which the serum data were obtained is shown above the serum data. Haptoglobin results on
pooled samples from the third experiment were as follows: high, 5.23 mg/dl; normal, 5.13 mg/dl;
deficient, <0.83 mg/dl. The reticulocytes in the same experiment were as follows: high, 0.4%; normal,
0.2%; deficient, 3.38%. Results presented are the mean ± 1 SD. *P c 0.05; tp c 0.001 as compared
to deficient. There was no significant difference in unconjugated bilirubin or lactate dehydrogenase.
RBC, erythrocytes; Hb, hemoglobin; Hct, hematocrit; MCV, mean cell volume; TIBC, total
iron-binding capacity; BDL, below the limits of detection. Detection limit is 0.83 mg/dl.
by the mononuclear-phagocyte system, while free haptoglo-
bin has a prolonged circulation time. Reticulocytes were
increased in vitamin E-deficient rats.
Phagocytosis of Old Erythrocytes from Normal Rats and
Erythrocytes of All Ages from Vitamin E-Deficient Rats. The
phagocytosis assay was performed on both age-separated and
unseparated erythrocytes from rats fed a diet containing
normal amounts of vitamin E or a diet deficient in vitamin E
(Table 2). Old erythrocytes obtained from rats fed a diet
containing normal amounts of vitamin E were phagocytized;
whereas young and middle-aged erythrocytes were not. In
contrast, young and middle-aged as well as old erythrocytes
were phagocytized when obtained from vitamin E-deficient
rats. There was a significant difference in phagocytosis
between erythrocytes obtained from normal rats and vitamin
E-deficient rats, even when unfractionated erythrocytes
were used for the assay (Table 2).
To determine whether the observed defects in the eryth-
rocytes obtained from vitamin E-deficient rats were revers-
ible and/or were the result of oxidative events occurring in
vitro during shipping, vitamin E was added to aliquots of
blood prior to shipping, 24 hr before the samples were tested.
It should be noted that the hematologic and serum studies
indicate that erythrocyte destruction is occurring in situ (e.g.,
reticulocyte count and haptoglobin). Thus, it is unlikely that
erythrocyte destruction is a phenomenon occurring only in
vitro, secondary to lack of vitamin E.
Addition of vitamin E in vitro to erythrocytes from vitamin
Table 2. Phagocytosis of unfractionated and age-separated
erythrocytes from vitamin E-deficient and normal rats
Erythrocyte
Vitamin E diet fraction % phagocytosis
Normal (50 mg/kg) Young 2 ± 3
Middle-aged 1 ± 1
Old 72 3
Unfractionated 13 ± 3
Deficient (0 mg/kg) Young 89 ± 1
Middle-aged 88 ± 1
Old 99 ±0
Unfractionated 87 + 1
The phagocytosis assay was performed with U937 cells. Erythro-
cytes were incubated with macrophages overnight at 370C in a
humidified atmosphere containing 5% CO2. Data are presented as the
mean ± 1 SD; n = 3. Diet is expressed as mg of vitamin E per kg of
diet.
E-deficient rats did not alter the membrane defect that
rendered these erythrocytes susceptible to phagocytosis
(Table 3). However, the erythrocytes that were "reconsti-
tuted" with vitamin E in vitro were less susceptible to
hemolysis during Coombs testing and storage than were cells
from vitamin E-deficient rats to which vitamin E had not been
added.
Erythrocytes from vitamin E-deficient rats both with and
without vitamin E added in vitro had a positive direct
antiglobulin test with antibodies to rat IgG.
Effect of Age and Vitamin E Deficiency on Anion Transport
by Erythrocytes. We suspected that anion transport might be
altered with cellular aging because our previous studies had
indicated that senescent-cell antigen is derived from band 3
by cleavage in the transmembrane anion transport region (27,
30, 31). If this suspicion proved to be correct, then we would
have a functional assay for aging of band 3, the major anion
transport protein of the erythrocyte membrane.
Transport studies on age-separated rat erythrocytes indi-
cated that anion transport decreased with age (Table 4). The
kinetic Michaelis constant (Ks,) increased and the maximal
velocity (Vm,,) decreased in old erythrocytes as compared to
middle-aged erythrocytes.
These data provided us with an assay of cellular function
to use to determine whether erythrocytes from vitamin
E-deficient rats exhibited characteristics of old erythrocytes
prematurely. Results of the anion transport studies on eryth-
rocytes from vitamin E-deficient rats revealed that their
Table 3. Phagocytosis of unseparated erythrocytes from vitamin
E-deficient and normal rats
Vitamin E
added in vitro, %
Vitamin E diet mg/dl phagocytosis
Macrophage source: WEHI-3 (mouse)
High (200 mg/kg) 0 5 ± 10
Normal (50 mg/kg) 0 24 ± 7
Deficient (0 mg/kg) 0 85 ± 3
Deficient (0 mg/kg) 1.6 92 ± 1
Macrophage source: U937 (human)
High (200 mg/kg) 0 5 ± 4
Normal (50 mg/kg) 0 25 ± 2
Deficient (0 mg/kg) 0 77 ± 4
Deficient (0 mg/kg) 1.6 64 ± 2
Data are presented as the mean ± 1 SD (n = 3).
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Table 4. Effect of cellular aging and vitamin E deficiency on
anion transport system of rat erythrocytes
V,,,, mol x 10-8
Km, mM per 108 cells per min
Cell age
Middle-aged 0.5 ± 0.2 41.8 ± 1.9
Old 1.6 ± 0.4* 17.3 ± 3.8*
Vitamin E diet
Normal 0.7 ± 0.1 41.2 ± 3.7
Deficient 2.0 ± 0.3* 16.2 ± 2.0*
Deficient + vitamin E 2.0 ± 0.3* 12.1 ± 1.7*
Results presented as the mean ± 1 SD. There is no statistical
difference between deficient, deficient + vitamin E, and old cells.
Km, concentration at half-maximal exchange, corresponding to an
apparent Michaelis-Menten constant (in mM); V.., maximal flux,
determined at 370C and pH 7.2.
*P ' 0.01.
anion transport was impaired, as was transport in old eryth-
rocytes (Table 4).
Effect of Age and Vitamin E Deficiency on Glyceraldehyde-
3-Phosphate Dehydrogenase Activity. We examined the eryth-
rocyte glyceraldehyde-3-phosphate dehydrogenase activity
for two reasons. First, glyceraldehyde-3-phosphate dehy-
drogenase is one of the enzymes that attaches to the cyto-
plasmic segment of band 3 (59). Second, we know from
previous studies on vitamin E-deficient rhesus monkeys that
glyceraldehyde-3-phosphate dehydrogenase activity is re-
duced in erythrocytes from these monkeys because of mod-
ifications in band 3 and not glyceraldehyde-3-phosphate
dehydrogenase (48).
Our initial studies indicated that glyceraldehyde-3-phos-
phate dehydrogenase did not bind to rat erythrocyte mem-
branes. All of the glyceraldehyde-3-phosphate dehydrog-
enase activity was present in the erythrocyte cytoplasm as
soluble enzyme. Thus, glyceraldehyde-3-phosphate dehy-
drogenase in rats differs from that of humans, in which a
fraction of the enzyme is membrane bound. Therefore, we
examined glyceraldehyde-3-phosphate dehydrogenase activ-
ity to compare erythrocytes from vitamin E-deficient rats to
old rat erythrocytes rather than as a "probe" for band 3.
Our studies indicate that glyceraldehyde-3-phosphate de-
hydrogenase activity is reduced in old erythrocytes and in
erythrocytes from vitamin E-deficient rats (Table 5). Thus,
cells from vitamin E-deficient rats behave like old cells with
respect to glyceraldehyde-3-phosphate dehydrogenase activ-
ity.
Examination of Erythrocyte Membranes from Vitamin E-
Deficient Rats Using Glycoprotein and Protein Stains, and
Immunoblotting with Antisera to Band 3. Differences were not
detected in protein or glycoprotein composition of erythro-
cyte membranes from control and vitamin E-deficient rats.
Although high molecular weight polypeptides or polymers
were detected with Coomassie blue staining of 2-16% poly-
acrylamide gels, there were no differences in the number or
amount of these polypeptides between control and experi-
mental samples. Immunoblotting studies revealed increased
breakdown products of band 3 in cells from vitamin E-
deficient rats (Fig. 1).
Table 5. Effect of cellular aging and vitamin E deficiency on
glyceraldehyde-3-phosphate dehydrogenase activity in rat
erythrocytes
Enzyme activity,
IU per 1010 cells
Cell age
Young 0.209 ± 0.045 (3)
Middle-aged 0.200 ± 0.022 (4)
Old 0.091 ± 0.030 (6)
Vitamin E diet
High 0.201 ± 0.038 (4)
Normal 0.199 ± 0.023 (7)
Deficient 0.103 ± 0.015 (7)
Deficient + vitamin E 0.116 ± 0.15 (3)
Enzyme activities are expressed as international units (IU) (mean
± 1 SD). The number of determinations is indicated in parentheses.
Glyceraldehyde-3-phosphate dehydrogenase values are significantly
lower for old than for middle-aged cells (P < 0.01). Deficient and
deficient + vitamin E glyceraldehyde-3-phosphate dehydrogenase
values are significantly lower than normal and high (P c 0.01).
these highly reactive oxygen species as metabolic interme-
diates appears to be an evolutionary consequence of aerobic
existence because the spin state of oxygen favors univalent
pathways of reduction (60).
We used vitamin E deficiency as a model for studying
oxidation because studies show that, in mammals, vitamin E
functions as an antioxidant, and because vitamin E deficiency
simulates conditions encountered in situ more closely than
does chemical treatment of cells in vitro.
The results presented here indicate that vitamin E defi-
ciency causes premature aging of erythrocytes and IgG
binding. Erythrocytes from vitamin E-deficient rats behave
like old erythrocytes in the phagocytosis assay, and in anion
transport and glyceraldehyde-3-phosphate dehydrogenase
activity. In addition, increased breakdown products of band
3 were observed in erythrocyte membranes from vitamin
E-deficient rats. We have not observed high molecular weight
complexes containing band 3 in membranes from vitamin
E-deficient rats or old cells aged in situ, except under
conditions that precipitate IgG (unpublished observations).
Other investigators have reported oligomers and polymers
ofband 3 in cells treated with ionophore A23187 plus calcium
(61) and in processed Triton extracts of old cells (32).
Although we have not been able to demonstrate high molec-
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As a mechanism for cellular aging and generation of senes-
cent-cell antigen, free-radical reactions and oxidation are
considered probable candidates (25). Most free-radical reac-
tions involve the reduction of molecular oxygen, leading to
the formation of highly reactive oxygen, species such as
superoxide anion (02-), hydroxyl radical ('OH), hydrogen
peroxide (H202), and singlet oxygen (102). The production of
AB AR
FIG. 1. Immunoblots of erythrocyte membrane proteins from
vitamin E-deficient and normal rats incubated with antibodies to
band 3. AB, amido black; AR, autoradiograph. Lanes: A, vitamin E
deficient; B, normal; C, high. Band designations are at left.
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ular weight band 3 complexes on cells aged in situ, we
speculate that they exist, but that they are short-lived
presumably because their presence is "life-threatening" to
the cell. We postulate that proteolytic cleavage of "cross-
linked" band 3 occurs to preserve membrane fluidity. We
think it unlikely that dimerization of band 3 generates
senescent-cell antigen as suggested by others (32). Data from
many laboratories indicate that band 3 normally exists as a
dimer or tetramer in the erythrocyte membrane (62, 63).
Senescent-cell antigen does not appear to be an exposed
galactose moiety as suggested by some investigators (64).
Recent evidence indicates that senescent-cell IgG does not
have an a- or ,6galactose specificity (22, 65) and that the
protein component of band 3 is required for binding of
senescent-cell IgG (65).
Anion transport across the membrane, which is the best-
defined physiological function of band 3, is reduced by both
cellular aging and vitamin E deficiency. Differences between
normal unseparated rat and human erythrocytes are observed
in the position of the concentration maximum [e.g., Km =
0.5-0.8 mM for rat cells and 3-5 mM for human cells
(unpublished observations)]. Also, the maximal sulfate trans-
port activity of rat erythrocytes was found to be 2-3 times as
high as that of human erythrocytes (unpublished observa-
tions), in agreement with the data reported by Gruber and
Deuticke (66) for phosphate ions.
The decrease in transport activity observed with vitamin E
deficiency is not reversed by addition of vitamin E in vitro.
This latter observation may indicate that the observed effects
are not caused by a direct effect of vitamin E on membrane
fluidity.
A decrease in band 3 functioning with erythrocyte age
supports the data indicating that alteration of band 3 occurs
during erythrocyte aging and generation of senescent-cell
antigen (27, 30, 31). Impairment of anion transport was
anticipated based on our previously published data indicating
that senescent-cell antigen is generated by cleavage of band
3 in the anion transport region (27).
Results of the experiments reported here suggest that
oxidation can cause aging ofband 3. We suspect that this may
be one of the mechanisms of cellular aging in situ. At this
time, it appears that general cellular damage such as lysis
(unpublished observations), cross-linking of band 3 by he-
moglobin (34), and oxidation can result in the generation of
senescent-cell antigen. This suggests to us that many differ-
ent cellular insults have a final common pathway that results
in generation of senescent-cell antigen.
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